06/25/2020 12:00 AM EDT
Source: United Nations Office for the Coordination of Humanitarian Affairs, Inter-Agency Standing Committee (IASC). Published: 6/25/2020. This 49-page document is an annex to the Interim Briefing Note Addressing Mental Health and Psychosocial Aspects of COVID-19 Outbreak. Sections include adapting psychological first aid for the COVID-19 context; continuation of comprehensive and clinical mental health and psychosocial support care in humanitarian settings during the COVID-19 pandemic; and mental health and psychosocial support considerations for children, adolescents, and families during the COVID-19 response. (PDF)
06/25/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/25/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the IntelliPlex SARS-CoV-2 Detection Kit. The IntelliPlex SARS-CoV-2 Detection Kit is authorized for use with respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider. (PDF)
06/25/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/25/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Fastplex Triplex SARS-CoV-2 Detection Kit (RT-digital PCR). The Fastplex Triplex SARS-CoV-2 Detection Kit (RT-digtial PCR) is authorized for use with oropharyngeal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
06/25/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/25/2020. This seven-page letter details the Emergency Use Authorization (EUA) for the DSL COVID-19 Assay for qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens (such as nasal, mid-turbinate, nasopharyngeal, and oropharyngeal swabs) and bronchioalveolarlavage (BAL) specimens from individuals suspected of COVID-19 by their healthcare provider. (PDF)
06/25/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 6/25/2020. Countries can use this 20-page checklist of hospital governance, structures, plans, and protocols to rapidly determine the current capacities of hospitals to respond to the COVID-19 pandemic and to identify gaps and major areas that require investment and action for the development of hospital readiness improvement plans. (PDF)
06/24/2020 12:00 AM EDT
Source: National Institutes of Health (NIH). Published: 6/24/2020. Traditional compartment models can be enriched by the judicious use of robust methods drawn from the field of artificial intelligence (AI) that allow us to model more accurately and more quickly the population and disease dynamics that are central to developing policies for prevention, detection, and treatment. This one-hour, three-minute presentation explores these approaches, including some that are currently in use, as well as a proposal for novel, next-generation machine learning tools for epidemiologic investigation. (Video or Multimedia)
06/24/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/24/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the MD Anderson High-throughput SARS-CoV-2 RT-PCR Assay that has been issued an Emergency Use Authorization (EUA) by FDA.This test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
05/01/2020 12:00 AM EDT
Source: Social Science in Humanitarian Action. Published: 5/2020. This four-page brief highlights key considerations when appraising health-seeking behaviors in the context of an epidemic outbreak. It provides guidance on the availability of relevant social science knowledge to adapt epidemic preparedness and response to the local context. Using the guidance will result in a mapping of crucial social science knowledge on health-seeking behavior and reveal areas for additional primary data collection. (PDF)
05/01/2020 12:00 AM EDT
Source: Social Science in Humanitarian Action. Published: 5/2020. This four-page brief can be used by healthcare providers, non-governmental organizations (NGOs), national and global-level policymakers, and industry actors to gain social science inputs in vaccine deployment efforts to provide practical solutions to reoccurring challenges, including vaccine refusal. (PDF)
No hay comentarios:
Publicar un comentario